NKMAX, LOC for Investment Attraction with Chinese Sugang Group

Investment of $50 Million in Training Group NKMAX

NKMAX announced on the 7th that it has signed a Letter of Commitment (LOC) for a large-scale investment attraction with Sugang Group, a leading medical and health services company in China.

Sugang Group plans to invest $50 million by participating in NKMAX's third-party allotment paid-in capital increase. NKMAX has established plans to distribute various products overseas with Sugang Group, including NK cell therapy (SNK) business, immune diagnostic kits (NK View Kit), and health functional foods.

Sugang Group has built a global sales and distribution network across China, the United States, Europe, and Asia, and possesses business experience and data in the medical and health services sector. It has partnered with JD.com, the number one e-commerce company in China, to jointly sell various health functional foods and medical consumables.

An NKMAX official stated, "Following the signing of the LOC with Sugang Group, we are in the process of advancing the main contract," and added, "Orders for our health functional food products, such as NK365, are being placed in China."

This content was produced with the assistance of AI translation services.